1. Prospective longitudinal study on fear of cancer recurrence in patients newly diagnosed with head and neck cancer
- Author
-
Esther Deuning‐Smit, José A. E. Custers, Špela Miroševič, Robert P. Takes, Femke Jansen, Johannes A. Langendijk, Chris H. J. Terhaard, Robert J. Baatenburg de Jong, C. René Leemans, Johannes H. Smit, Linda Kwakkenbos, Irma M. Verdonck‐de Leeuw, Judith B. Prins, Otorhinolaryngology and Head and Neck Surgery, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Damage and Repair in Cancer Development and Cancer Treatment (DARE), Otolaryngology / Head & Neck Surgery, CCA - Cancer Treatment and quality of life, APH - Mental Health, Psychiatry, APH - Methodology, Amsterdam Neuroscience - Complex Trait Genetics, Amsterdam Neuroscience - Mood, Anxiety, Psychosis, Stress & Sleep, and APH - Personalized Medicine
- Subjects
fear of cancer recurrence ,Breast Neoplasms ,chemical and pharmacologic phenomena ,PROGRESSION ,Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18] ,Experimental Psychopathology and Treatment ,Cohort Studies ,All institutes and research themes of the Radboud University Medical Center ,DISTRESS ,SDG 3 - Good Health and Well-being ,QUALITY-OF-LIFE ,Humans ,trajectories ,Longitudinal Studies ,Prospective Studies ,PREDICTORS ,SURVIVORS ,1ST YEAR ,SELF-EFFICACY ,MENTAL ADJUSTMENT ,Fear ,latent class growth analysis ,Women's cancers Radboud Institute for Health Sciences [Radboudumc 17] ,coping ,PSYCHOMETRIC PROPERTIES ,Otorhinolaryngology ,Head and Neck Neoplasms ,COPING STRATEGIES ,Female ,head and neck cancer ,Neoplasm Recurrence, Local ,Rare cancers Radboud Institute for Health Sciences [Radboudumc 9] - Abstract
Contains fulltext : 246727.pdf (Publisher’s version ) (Open Access) Background: This study assessed the course of fear of cancer recurrence (FCR) in patients newly diagnosed with head and neck cancer (HNC), identified FCR trajectories and factors associated with FCR trajectories. Methods: Six hundred and seventeen HNC patients from the NET-QUBIC cohort study completed the Cancer Worry Scale-6 at diagnosis, 3 and 6 months post-treatment. FCR trajectories were identified using Latent Class Growth Analysis. Associations were explored between FCR trajectories and baseline demographic and medical variables, coping and self-efficacy. Results: Overall, FCR decreased slightly between baseline and 3 months post-treatment and remained stable up to 6 months. Two FCR trajectories were identified: "high stable" (n = 125) and "low declining" (n = 492). Patients with high stable FCR were younger, reported more negative adjustment, passive coping, and reassuring thoughts, and less avoidance. Conclusions: The majority of HNC patients have low declining FCR after diagnosis, but one in five patients experience persistent high FCR up to 6 months post-treatment. 12 p.
- Published
- 2022